Mani Foroohar

Stock Analyst at Leerink Partners

(2.22)
# 2,686
Out of 4,886 analysts
164
Total ratings
48.31%
Success rate
n/a
Average return

Stocks Rated by Mani Foroohar

Rocket Pharmaceuticals
May 28, 2025
Downgrades: Market Perform
Price Target: $37$8
Current: $2.96
Upside: +170.27%
Lexeo Therapeutics
Mar 24, 2025
Maintains: Outperform
Price Target: $19$18
Current: $4.44
Upside: +305.86%
Recursion Pharmaceuticals
Feb 28, 2025
Maintains: Market Perform
Price Target: $7$6
Current: $5.36
Upside: +11.94%
4D Molecular Therapeutics
Jan 13, 2025
Maintains: Outperform
Price Target: $31$27
Current: $4.22
Upside: +539.81%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45$72
Current: $20.28
Upside: +255.03%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $1.46
Upside: +1,064.38%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47$49
Current: $50.25
Upside: -2.48%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47$46
Current: $43.19
Upside: +6.51%
Wave Life Sciences
Oct 16, 2024
Maintains: Outperform
Price Target: $20$22
Current: $6.95
Upside: +216.77%
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53$62
Current: $41.34
Upside: +49.98%
Initiates: Outperform
Price Target: $13
Current: $12.65
Upside: +2.77%
Initiates: Outperform
Price Target: $29
Current: $21.42
Upside: +35.39%
Maintains: Outperform
Price Target: $165$230
Current: $19.03
Upside: +1,108.62%
Downgrades: Market Perform
Price Target: $12$4
Current: $5.42
Upside: -26.20%
Upgrades: Outperform
Price Target: n/a
Current: $8.74
Upside: -
Initiates: Outperform
Price Target: $31
Current: $3.80
Upside: +715.79%
Initiates: Outperform
Price Target: $7
Current: $0.63
Upside: +1,006.19%
Downgrades: Market Perform
Price Target: $40
Current: $17.54
Upside: +128.05%
Downgrades: Underperform
Price Target: $111$93
Current: $32.54
Upside: +185.80%
Maintains: Outperform
Price Target: $86$84
Current: $11.12
Upside: +655.40%
Maintains: Market Perform
Price Target: $6$7
Current: $2.86
Upside: +144.76%
Maintains: Outperform
Price Target: $81$77
Current: $20.30
Upside: +279.31%
Maintains: Market Perform
Price Target: $144$143
Current: $317.50
Upside: -54.96%
Maintains: Market Perform
Price Target: $5$6
Current: $5.84
Upside: +2.74%
Maintains: Outperform
Price Target: $75$76
Current: $54.82
Upside: +38.64%
Maintains: Outperform
Price Target: $30$34
Current: $1.60
Upside: +2,025.00%
Maintains: Market Perform
Price Target: $50$20
Current: $2.40
Upside: +733.33%